Fundacao Gimm - Gulbenkian Institute for Molecular Medicine

Fundacao Gimm - Gulbenkian Institute for Molecular Medicine is a research organisation in Lisboa, Portugal that has taken part in 76 EU-funded projects since 2015, receiving €57.8M in EU funding and leading 33 as coordinator.

EU funding received€57.8M
EU projects76
As coordinator33
Running now46
First EU project2015
Latest project2027
CountryPortugal
EU registration (PIC)877027732
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Fundacao Gimm - Gulbenkian Institute for Molecular Medicine's own share of each project, not the project's full budget.

  • Horizon Europe€42.4M · 58 projects
  • Horizon 2020€15.3M · 17 projects
  • Single Market Programme (SMP)€78k · 1 project

Projects

76 EU-funded projects, newest first. Fundacao Gimm - Gulbenkian Institute for Molecular Medicine led 33 of them as coordinator. Each links to the official record.

  • EvoBacNicheCoordinator

    Diet-driven evolution in a human gut commensal bacterium: impact on niche adaptation and host physiology

    Horizon Europe · 2027–2029 · Project on CORDIS ↗

    €191ktheir share
  • DuoLipo-TNPAssociated partner

    DuoLipo-TNP: Dual-Responsive Liposome Platform for Selective Delivery of Triphosphate Nucleotide Prodrugs in Triple-Negative Breast Cancer

    Horizon Europe · 2027–2029 · Project on CORDIS ↗

  • KiTE 2.0Associated partner

    Kiel Training for Excellence

    Horizon Europe · 2027–2031 · Project on CORDIS ↗

  • BREATHAssociated partner

    Revolutionizing Blood Storage Through Gas-Based Preservation

    Horizon Europe · 2027–2028 · Project on CORDIS ↗

  • DECODESPartner

    Deciphering the Splicing Code in Human Disease

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €279ktheir share
  • VacciNEXTPartner

    Next generation therapeutic vaccine for targeted cancer treatment

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €718ktheir share
  • KILLBILLCoordinator

    A metabolic-based defense strategy against malaria

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €2.5Mtheir share
  • ISIDORe IIAssociated partner

    INTEGRATED SERVICES FOR INFECTIOUS DISEASE OUTBREAK RESEARCH II

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • TEaR-fluCoordinator

    Tfh determinants for effective responses to influenza vaccination in older individuals

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €207ktheir share
  • DYNAMISAssociated partner

    IDIBAPS Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • EvoMG-DNPartner

    Evolutionary Medical Genomics Doctoral Network

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €559ktheir share
  • LowDataMLAssociated partner

    Low Data Machine Learning for Sustainable Chemical Sciences

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • MicroDialogueCoordinator

    Unraveling the potential of Quorum Sensing inter-species dialogue to restore microbiota’s community dynamics.

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €191ktheir share
  • BIOinFILMCoordinator

    Shedding light on the key molecular determinants regulating 3D diffusion and activity of antimicrobials in bacterial biofilms.

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €157ktheir share
  • RhoptryPhosCoordinator

    Defining the rhoptry kinome in Plasmodium falciparum and its importance for invasion of red blood cells

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €191ktheir share
  • MDR-RAPartner

    Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €144ktheir share
  • ENDAMRPartner

    Exploring Novel Drivers of Anti-Microbial Resistance

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €243ktheir share
  • BIOMICSCoordinator

    Fostering Excellent Research, Training and Innovation in Biomedical Data Science

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €822ktheir share
  • CarrerasPathfindersAssociated partner

    Enabling the next generation in search of blood cancer cures

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • PoEMMCoordinator

    Plasmodium Exploitation of Liver-specific Methionine Metabolism

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €173ktheir share
  • CD-ResOMicsCoordinator

    Elucidating the cellular basis of therapeutic resistance in Crohn's disease

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €173ktheir share
  • INFRAPLUSPartner

    Enhancing and Evolving INFRAFRONTIER Disease Modelling Capacity to Enable Breakthrough Research

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €50ktheir share
  • LeishMalCoordinator

    Immune-mediated reciprocal impact of concomitant infection by Plasmodium and Leishmania parasites

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €157ktheir share
  • 3DNanoScope4AllCoordinator

    3D Nanoscope: a highly accessible, high-performance device for live cell nanoscopy

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €127ktheir share
  • META_FUNCoordinator

    Mapping metabolic responses to understand coexistence and community functioning

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €1.5Mtheir share
  • TRIADPartner

    TRIAD: Enhancing Synergism on Telomere Function in Health and Disease

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €397ktheir share
  • PANERISPartner

    Pan-European Network for Neuroscience Research Infrastructure and Strengthening of Support capacities

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €236ktheir share
  • TissueLymphOmicsCoordinator

    Cellular crosstalk driving Tertiary Lymphoid Structure formation across tissues

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €157ktheir share
  • immSC-AgingFateCoordinator

    The Interplay of Aging, Immune Signaling and Stem Cell Function

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €2.0Mtheir share
  • SMARTdrugsPartner

    SUPRAMOLECULAR AGENTS AS RADIOTHERANOSTIC DRUGS

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €526ktheir share
  • AVITHRAPIDPartner

    Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €543ktheir share
  • EvaMobsPartner

    Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €655ktheir share
  • MicrobiotaNeuroTalkCoordinator

    Trafficking mechanisms and physiological factors mediating a direct gut microbiota-brain neuron interaction

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.7Mtheir share
  • VirulenceControlCoordinator

    The role of an expanded family of exported effector kinases in environmental sensing and regulation of virulence in human malaria.

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.8Mtheir share
  • EvoInHiCoordinator

    Evolution in the Gut in Health and Disease

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.9Mtheir share
  • RT-SuperESPartner

    Real-Time high-content Super-Resolution Imaging of ES Cell States

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €8ktheir share
  • MAGICPartner

    Next-generation models and genetic therapies for rare neuromuscular diseases

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €500ktheir share
  • OptiViVaxPartner

    Optimising a High Efficacy Plasmodium vivax Malaria Vaccine

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €496ktheir share
  • PASSAGECoordinator

    Plasmodium liver stage schizogony: high replication and genetic diversity

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €2.5Mtheir share
  • HCMSpliceAOCCoordinator

    Molecular design and application of splice-switching antibody-oligonucleotide conjugate for hypertrophic cardiomyopathy-related MYBPC3 splice modulation.

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €157ktheir share
Show 36 more projects
  • GIMM-CARECoordinator

    GIMM-CARE: BOOSTING CLINICAL RESEARCH FOR THE BENEFIT OF SOCIETY

    Horizon Europe · 2023–2029 · Project on CORDIS ↗

    €13.0Mtheir share
  • GEREMYPartner

    Gene Therapy for treatment of rare inherited Arrhythmogenic Cardiomyopathy

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €508ktheir share
  • STRATA-FITPartner

    Stratification of Rheumatoid Arthritis: CompuTational models to personalise mAnagement strategies for difFIcult-to-Treat disease

    Horizon Europe · 2023–2029 · Project on CORDIS ↗

    €907ktheir share
  • MusclePlateCoordinator

    Human skeletal muscle platform for disease modelling and high-throughput drug screening

    Horizon Europe · 2023–2024 · Project on CORDIS ↗

    €150ktheir share
  • ISOBIOTICSPartner

    Isotopic Labeling of Biotherapeutics

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €487ktheir share
  • SweetEggsCoordinator

    The impact of germline metabolic reprogramming on reproduction and physiology

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €1.5Mtheir share
  • CarrerasLeadersAssociated partner

    Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • Aqua-SynapsePartner

    The health benefits of deuterium depletion on synaptic function, regional metabolism, and behaviour

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €101ktheir share
  • ENDOTARGETPartner

    Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic targets for Arthritis

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €365ktheir share
  • METHYLOMICPartner

    DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €306ktheir share
  • BEE_GEMSCoordinator

    Genetic factors Enabling Microbiome Symbioses: Bees as a natural model system

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €1.1Mtheir share
  • AI4LIFEPartner

    Artificial Intelligence for Image Data Analysis in the Life Sciences

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €24ktheir share
  • LEAP-BIOPartner

    IP Licensing intermediary services for EArly-Stage assets in Pharma & BIOtech

    Single Market Programme (SMP) · 2022–2024 · Project on the EU portal ↗

    €78ktheir share
  • CANCERNAPartner

    RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €551ktheir share
  • miRToTALLCoordinator

    A microRNA-regulated cell death-inducing gene therapy for T-cell Acute Lymphoblastic Leukemia

    Horizon Europe · 2022–2024 · Project on CORDIS ↗

    €150ktheir share
  • END-VOCPartner

    ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOC

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €454ktheir share
  • RAISEPartner

    Researchers in Action for Inclusion in Science and Education

    Horizon Europe · 2022–2024 · Project on CORDIS ↗

    €16ktheir share
  • SynEryPartner

    Bottom-up reconstruction of a Synthetic Erythrocyte

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €358ktheir share
  • ISIDORePartner

    Integrated Services for Infectious Disease Outbreak Research

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €460ktheir share
  • SelfDriving4DSRPartner

    Enabling Live-Cell 4D Super-Resolution Microscopy Guided by Artificial Intelligence

    Horizon 2020 · 2021–2027 · Project on CORDIS ↗

    €109ktheir share
  • ENLIGHT-TENplusPartner

    European Network Linking Informatics and Genomics of Helper T cells in Tissues

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €238ktheir share
  • BRAINTEASERPartner

    BRinging Artificial INTelligencE home for a better cAre of amyotrophic lateral sclerosis and multiple SclERosis

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €363ktheir share
  • EpiEpiNetCoordinator

    Epileptogenesis and Epilepsy Network: from genes, synapses and circuits to pave the way for novel drugs and strategies

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €588ktheir share
  • GelGeneCircuitPartner

    Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic circuits.

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

  • IDEA-FASTPartner

    Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

    €342ktheir share
  • makingtheretinaCoordinator

    Principles of retinal neuronal lamination from zebrafish to humans

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

    €560ktheir share
  • SIMICACoordinator

    Site-selective protein-modification chemistries for antibody-drug conjugates (ADCs)

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €350ktheir share
  • NOVIRUSES2BRAINCoordinator

    ''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €2.1Mtheir share
  • 3TRPartner

    Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

    Horizon 2020 · 2019–2028 · Project on CORDIS ↗

    €286ktheir share
  • RiboMedCoordinator

    RNA in disease

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €425ktheir share
  • ArpComplexityPartner

    Defining the role of Arp2/3 complex diversity at multiple scales of biology

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

    €3.2Mtheir share
  • SAFE-N-MEDTECHPartner

    SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €806ktheir share
  • FatTrypCoordinator

    Exploring the hidden life of African trypanosomes: parasite fat tropism and implications for disease

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €2.0Mtheir share
  • TwinnToInfectCoordinator

    Unleash IMM’s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

    €894ktheir share
  • SynaNetCoordinator

    Neurologic and Psychiatric Disorders: from synapses to networks

    Horizon 2020 · 2016–2018 · Project on CORDIS ↗

    €525ktheir share
  • EXCELLtoINNOVCoordinator

    Leverage research EXCELLence and INNOVation potential of Instituto de Medicina Molecular (IMM) through translational biomedical research in immunity and infection.

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €2.5Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • RNA
  • agriculture
  • alzheimer
  • amyotrophic lateral sclerosis
  • antibiotic resistance
  • antibiotics
  • artificial intelligence
  • bacteriology
  • biochemistry
  • biological interactions
  • biomaterials
  • biomolecules

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime